Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement

Emma Mooney; Marius Rademaker; Rebecca Dailey; Ben S Daniel; Catherine Drummond; Gayle Fischer; Rachael Foster; Claire Grills; Anne Halbert; Sarah Hill; Emma King; Elizabeth Leins; Vanessa Morgan; Roderic J Phillips; John Relic; Michelle Anne Rodrigues; Laura Scardamaglia; Saxon Smith; John Su; Orli Wargon; David Orchard

doi:10.1111/ajd.12313

Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement

Emma Mooney, Marius Rademaker, Rebecca Dailey, Ben S Daniel, Catherine Drummond, Gayle Fischer, Rachael Foster, Claire Grills, Anne Halbert, Sarah Hill, Emma King, Elizabeth Leins, Vanessa Morgan, Roderic J Phillips, John Relic, Michelle Anne Rodrigues, Laura Scardamaglia, Saxon Smith, John Su, Orli WargonDavid Orchard

Paediatrics Monash Health

Research output: Contribution to journal › Review Article › Research › peer-review

1 Citation (Scopus)

Abstract

Atopic eczema is a chronic inflammatory disease affecting about 30 of Australian and New Zealand children. Severe eczema costs over AUD?6000/year per child in direct medical, hospital and treatment costs as well as time off work for caregivers and untold distress for the family unit. In addition, it has a negative impact on a child s sleep, education, development and self-esteem. The treatment of atopic eczema is complex and multifaceted but a core component of therapy is to manage the inflammation with topical corticosteroids (TCS). Despite this, TCS are often underutilised by many parents due to corticosteroid phobia and unfounded concerns about their adverse effects. This has led to extended and unnecessary exacerbations of eczema for children.

Original language	English
Pages (from-to)	241-251
Number of pages	11
Journal	Australasian Journal of Dermatology
Volume	56
DOIs	https://doi.org/10.1111/ajd.12313
Publication status	Published - 2015

Access to Document

10.1111/ajd.12313

Cite this

Mooney, E., Rademaker, M., Dailey, R., Daniel, B. S., Drummond, C., Fischer, G., Foster, R., Grills, C., Halbert, A., Hill, S., King, E., Leins, E., Morgan, V., Phillips, R. J., Relic, J., Rodrigues, M. A., Scardamaglia, L., Smith, S., Su, J., ... Orchard, D. (2015). Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement. Australasian Journal of Dermatology, 56, 241-251. https://doi.org/10.1111/ajd.12313

@article{2da85f0806184fb1926af81341393536,

title = "Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement",

abstract = "Atopic eczema is a chronic inflammatory disease affecting about 30 of Australian and New Zealand children. Severe eczema costs over AUD?6000/year per child in direct medical, hospital and treatment costs as well as time off work for caregivers and untold distress for the family unit. In addition, it has a negative impact on a child s sleep, education, development and self-esteem. The treatment of atopic eczema is complex and multifaceted but a core component of therapy is to manage the inflammation with topical corticosteroids (TCS). Despite this, TCS are often underutilised by many parents due to corticosteroid phobia and unfounded concerns about their adverse effects. This has led to extended and unnecessary exacerbations of eczema for children.",

author = "Emma Mooney and Marius Rademaker and Rebecca Dailey and Daniel, {Ben S} and Catherine Drummond and Gayle Fischer and Rachael Foster and Claire Grills and Anne Halbert and Sarah Hill and Emma King and Elizabeth Leins and Vanessa Morgan and Phillips, {Roderic J} and John Relic and Rodrigues, {Michelle Anne} and Laura Scardamaglia and Saxon Smith and John Su and Orli Wargon and David Orchard",

year = "2015",

doi = "10.1111/ajd.12313",

language = "English",

volume = "56",

pages = "241--251",

journal = "Australasian Journal of Dermatology",

issn = "0004-8380",

publisher = "Wiley-Blackwell",

}

Mooney, E, Rademaker, M, Dailey, R, Daniel, BS, Drummond, C, Fischer, G, Foster, R, Grills, C, Halbert, A, Hill, S, King, E, Leins, E, Morgan, V, Phillips, RJ, Relic, J, Rodrigues, MA, Scardamaglia, L, Smith, S, Su, J, Wargon, O & Orchard, D 2015, 'Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement', Australasian Journal of Dermatology, vol. 56, pp. 241-251. https://doi.org/10.1111/ajd.12313

TY - JOUR

T1 - Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement

AU - Mooney, Emma

AU - Rademaker, Marius

AU - Dailey, Rebecca

AU - Daniel, Ben S

AU - Drummond, Catherine

AU - Fischer, Gayle

AU - Foster, Rachael

AU - Grills, Claire

AU - Halbert, Anne

AU - Hill, Sarah

AU - King, Emma

AU - Leins, Elizabeth

AU - Morgan, Vanessa

AU - Phillips, Roderic J

AU - Relic, John

AU - Rodrigues, Michelle Anne

AU - Scardamaglia, Laura

AU - Smith, Saxon

AU - Su, John

AU - Wargon, Orli

AU - Orchard, David

PY - 2015

Y1 - 2015

N2 - Atopic eczema is a chronic inflammatory disease affecting about 30 of Australian and New Zealand children. Severe eczema costs over AUD?6000/year per child in direct medical, hospital and treatment costs as well as time off work for caregivers and untold distress for the family unit. In addition, it has a negative impact on a child s sleep, education, development and self-esteem. The treatment of atopic eczema is complex and multifaceted but a core component of therapy is to manage the inflammation with topical corticosteroids (TCS). Despite this, TCS are often underutilised by many parents due to corticosteroid phobia and unfounded concerns about their adverse effects. This has led to extended and unnecessary exacerbations of eczema for children.

AB - Atopic eczema is a chronic inflammatory disease affecting about 30 of Australian and New Zealand children. Severe eczema costs over AUD?6000/year per child in direct medical, hospital and treatment costs as well as time off work for caregivers and untold distress for the family unit. In addition, it has a negative impact on a child s sleep, education, development and self-esteem. The treatment of atopic eczema is complex and multifaceted but a core component of therapy is to manage the inflammation with topical corticosteroids (TCS). Despite this, TCS are often underutilised by many parents due to corticosteroid phobia and unfounded concerns about their adverse effects. This has led to extended and unnecessary exacerbations of eczema for children.

UR - http://onlinelibrary.wiley.com/doi/10.1111/ajd.12313/abstract;jsessionid=C710925A49C9AFECA38F08AB8E1C00F1.f03t03?systemMessage=Wiley+Online+Library+wi

U2 - 10.1111/ajd.12313

DO - 10.1111/ajd.12313

M3 - Review Article

VL - 56

SP - 241

EP - 251

JO - Australasian Journal of Dermatology

JF - Australasian Journal of Dermatology

SN - 0004-8380

ER -

Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement

Abstract

Access to Document

Other files and links

Cite this